KR930702508A - T 전구세포계의 배양방법 - Google Patents

T 전구세포계의 배양방법

Info

Publication number
KR930702508A
KR930702508A KR1019930700661A KR930700661A KR930702508A KR 930702508 A KR930702508 A KR 930702508A KR 1019930700661 A KR1019930700661 A KR 1019930700661A KR 930700661 A KR930700661 A KR 930700661A KR 930702508 A KR930702508 A KR 930702508A
Authority
KR
South Korea
Prior art keywords
culture method
cell culture
progenitor cell
nutrient medium
oxygen dissolved
Prior art date
Application number
KR1019930700661A
Other languages
English (en)
Other versions
KR0152100B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR930702508A publication Critical patent/KR930702508A/ko
Application granted granted Critical
Publication of KR0152100B1 publication Critical patent/KR0152100B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0636T lymphocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5158Antigen-pulsed cells, e.g. T-cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/02Atmosphere, e.g. low oxygen conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50Cell markers; Cell surface determinants
    • C12N2501/59Lectins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/11Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1019930700661A 1991-07-04 1992-07-01 분화항원 표현형상 또는 기능상 분화, 성숙한 t세포를 제조하는 방법 KR0152100B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25828391 1991-07-04
JP91-258283 1991-07-04
PCT/JP1992/000829 WO1993001277A1 (fr) 1991-07-04 1992-07-01 Procede de culture d'une lignee de cellules precurseurs t

Publications (2)

Publication Number Publication Date
KR930702508A true KR930702508A (ko) 1993-09-09
KR0152100B1 KR0152100B1 (ko) 1998-10-01

Family

ID=17318102

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930700661A KR0152100B1 (ko) 1991-07-04 1992-07-01 분화항원 표현형상 또는 기능상 분화, 성숙한 t세포를 제조하는 방법

Country Status (7)

Country Link
US (2) US5476780A (ko)
EP (1) EP0552372B1 (ko)
KR (1) KR0152100B1 (ko)
AT (1) ATE180830T1 (ko)
CA (1) CA2090677C (ko)
DE (1) DE69229333D1 (ko)
WO (1) WO1993001277A1 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2206449A1 (en) * 1994-12-01 1996-06-06 Beth Israel Deaconess Medical Center, Inc. In vitro t-lymphopoiesis system
JP3818324B2 (ja) * 1996-03-26 2006-09-06 三菱瓦斯化学株式会社 ガス濃度調節剤及び低酸素濃度環境の調節方法
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7393652B2 (en) 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7544678B2 (en) 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
WO2004080283A2 (en) 2003-03-07 2004-09-23 The Trustees Of Columbia University, In The City Of New York Type 1 ryanodine receptor-based methods
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
WO2019174842A1 (en) 2018-03-13 2019-09-19 Oxacell Ag Cell products with improved stability and uses thereof
US20210324331A1 (en) * 2020-04-15 2021-10-21 Amgen Inc. Process for generating genetically engineered autologous t cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284724A (en) * 1977-08-25 1981-08-18 Hideki Fukuda Method of highly concentrated cultivation of yeasts
DE2940446C2 (de) * 1979-10-05 1982-07-08 B. Braun Melsungen Ag, 3508 Melsungen Züchtung von tierischen Zellen in Suspensions- und Monolayerkulturen in Fermentationsgefäßen
US4448879A (en) * 1981-03-26 1984-05-15 Hooper Trading Company High yield process for in vitro production of serum-free and mitogen-free interleukin-2
JPS6192566A (ja) * 1984-10-12 1986-05-10 Wakunaga Seiyaku Kk 抗体産生細胞の調製方法
JPS61166393A (ja) * 1985-01-14 1986-07-28 Mitsubishi Chem Ind Ltd Bリンパ球及び/又はtリンパ球の培養法
US4720462A (en) * 1985-11-05 1988-01-19 Robert Rosenson Culture system for the culture of solid tissue masses and method of using the same
EP0302894B1 (en) * 1986-04-28 1992-11-19 Endotronics Inc. Method of culturing leukocytes
EP0420876A1 (en) * 1988-05-23 1991-04-10 Massachusetts Institute Of Technology Growth of animal cells at high oxygen concentration
JP2837856B2 (ja) * 1988-11-11 1998-12-16 イハラケミカル工業株式会社 リンフォカイン活性化キラー細胞及びその製造法
JP2870851B2 (ja) * 1989-09-21 1999-03-17 富士レビオ株式会社 ヒト成熟t細胞株
US5147784A (en) * 1990-04-12 1992-09-15 Systemix, Inc. T-lymphocyte progenitor cell assay

Also Published As

Publication number Publication date
ATE180830T1 (de) 1999-06-15
EP0552372B1 (en) 1999-06-02
KR0152100B1 (ko) 1998-10-01
EP0552372A1 (en) 1993-07-28
CA2090677C (en) 1996-08-27
US5792655A (en) 1998-08-11
CA2090677A1 (en) 1993-01-05
EP0552372A4 (en) 1994-11-30
DE69229333D1 (de) 1999-07-08
WO1993001277A1 (fr) 1993-01-21
US5476780A (en) 1995-12-19

Similar Documents

Publication Publication Date Title
KR930702508A (ko) T 전구세포계의 배양방법
DE3661273D1 (en) Method and apparatus for carrying out cell culture
CA2107036A1 (en) Cell Culture Insert
GB2252562B (en) Wound dressing comprising cultured cells
DE69334286D1 (de) Verfahren zur Bestimmung der Neigung von Bakterien zum gelöstem Sauerstofinstabilität
EP0269444A3 (en) Apparatus and method for mass transfer involving biological/pharmaceutical media
IL94611A0 (en) Cell culture systems and media
SE8306190D0 (sv) A process and a device for improved oxygenation of biological cultures
ATE163969T1 (de) Vorrichtung zur kultivierung von mikroorganismen
CA2267655A1 (en) Assay using marked microbial host cell strains
DK0494333T3 (da) Apparat til subkultur med flere faste næringsmedier
ES2082242T3 (es) Procedimiento y aparato para el cultivo superficial de celulas provistas de nucleos y sustancias dependientes de un cultivo celular.
Battley et al. Studies on the anaerobic growth of a biotype of Chlorella vulgaris
Allen et al. Cellular electrophysiology XXII. Effects of imposed potentiostasis on microbial systems
EP0233937A4 (en) FERMENTATION PROCESSES FOR THE PRODUCTION OF HEPATITIS VACCINES.
IT1252598B (it) Linea cellulare tiroidea di origine murina coltivabile in vitro e corredo diagnostico comprendente la stessa
IS3897A (is) Aðferð til framleiðslu á hitakærum örverum í miklum mæli
IT1247494B (it) Processo per la coltura di cellule di mammifero ingegnerizzate con l`impiego di microcarries in cui lo scale-up si effettua con terreni di cultura tradizionali senza utilizzare enzimi proteolitici

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee